LBF20307PG41: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
{{Lipid/Header}} | |||
{{Metabolite | {{Metabolite | ||
Line 10: | Line 12: | ||
|UV Spectra=<FONT FACE="Symbol">l</FONT><SUB><FONT SIZE=-1>m</FONT></SUB><SUB><FONT SIZE=-1>a</FONT></SUB><SUB><FONT SIZE=-1>x</FONT></SUB> 217 nm(<FONT FACE="Symbol">e</FONT>9050))[[Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124}}]] | |UV Spectra=<FONT FACE="Symbol">l</FONT><SUB><FONT SIZE=-1>m</FONT></SUB><SUB><FONT SIZE=-1>a</FONT></SUB><SUB><FONT SIZE=-1>x</FONT></SUB> 217 nm(<FONT FACE="Symbol">e</FONT>9050))[[Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124|{{RelationTable/GetFirstAuthor|Reference:Bundy_GL:Daniels_EG:Lincoln_FH:Pike_JE:,J. Am. Chem. Soc.,1972,94,2124}}]] | ||
}} | }} | ||
{{Lipid/Footer}} |
Revision as of 13:00, 26 July 2009
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR8054 |
LipidMaps | LMFA03010100 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20307PG41 |
5-trans-prostaglandin A2 | |
---|---|
Structural Information | |
(5E, 13E) - (8R,12S,15S) -15-hydroxy-9-oxoprost-5,10,13-trienoic acid | |
| |
Formula | C20H30O4 |
Exact Mass | 334.21440944799997 |
Average Mass | 334.4498 |
SMILES | C(CC[C@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C=CC(=O)1)CC |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | HREIMS m/z 478.2998 for TMS derivative C26H46O4 Si2, calcd 478.2932. Bundy_GL et al. |
UV Spectra | lmax 217 nm(e9050)) Bundy_GL et al. |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|